Patents by Inventor Mathias Svahn

Mathias Svahn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALLOGENEIC COMPOSITION FOR THE TREATMENT OF COVID-19
    Publication number: 20230302056
    Abstract: The present disclosure relates to the use of allogeneic populations of mesenchymal stem/stromal cells and related compositions, which populations and compositions comprise cells pooled from multiple donors, in the treatment and/or prevention of COVID-19 infection or for use in the treatment and/or prevention of symptoms associated with COVID-19 infection. The present disclosure also relates to methods for obtaining said compositions.
    Type: Application
    Filed: August 13, 2021
    Publication date: September 28, 2023
    Inventors: Mathias SVAHN, Johanna DAHLLUND, Bahareh KHALAJ, Lindsay Catrina DAVIES
  • ALLOGENEIC COMPOSITION FOR THE TREATMENT OF CNS DISORDERS
    Publication number: 20220323504
    Abstract: The present disclosure relates to allogeneic populations of mesenchymal stem/stromal cells and related compositions, which populations and compositions comprise cells pooled from multiple donors, and their use in therapy and/or prevention of inflammatory, autoimmune, transplant related and CNS disorders, in particular CNS such as Amyotrophic Lateral Sclerosis. The present disclosure also relates to methods for obtaining said compositions.
    Type: Application
    Filed: August 14, 2020
    Publication date: October 13, 2022
    Inventors: Mathias SVAHN, Johanna DAHLLUND, Bahareh KHALAJ, Lindsay Catrina DAVIES
  • HYBRIDIZATION-STABILIZING CONSTRUCT
    Publication number: 20100041738
    Abstract: A Z-shaped construct having the capacity to hybridize to double stranded DNA in a trans fashion to affect transcription is produced from at least two oligonucleotides, connected to each other, wherein the oligonucleotides are connected to one another through one of sequence specific Watson-Crick base pairing; a covalent linker or a covalent bond directly between the backbones or the bases of said oligonucleotides; or a non-covalent linker or a non-covalent bond directly between the backbones or the bases of said oligonucleotides.
    Type: Application
    Filed: June 20, 2006
    Publication date: February 18, 2010
    Applicant: AVARIS AB
    Inventors: Edvard Smith, Mathias Svahn, Rongbin Ge
  • Nucleic Acid Complex
    Publication number: 20080206869
    Abstract: The present invention relates to modification of nucleic acids for specific delivery in vitro and in vivo. More specifically, the present invention relates to modification of RNA or DNA molecules in order to add functions in terms of delivery and specificity to RNA interference or antisense technology. A specific binding domain is incorporated into the nucleic acid to which a complementary nucleic acid, conjugated to a biologically active molecule, can hybridize.
    Type: Application
    Filed: January 23, 2006
    Publication date: August 28, 2008
    Applicant: AVARIS AB
    Inventors: Edvard Smith, Mathias Svahn, Oscar Simonson